2025年

Sakurai K, Ashikawa Y, Imaoka Y, Ohshima K, Sano F, Arai A, Yagishita N, Aray N, Nakashima M, Horibe E, Sato T, Yamano Y.
A Case of Adult T-Cell Leukemia Following Satralizumab Treatment for Neuromyelitis Optica Spectrum Disorder.
Internal Medicine, 2025 Jun, in press.🆕

Saito M, Sato T, Hasegawa H, Tanabe K, Yoshida-Furihata H, Horibe E, Coler-Reilly A, Nojiri N, Yamauchi S, Nakashima M, Araya N, Yagishita N, Takahashi K, Sasaki D, Sagara Y, Uchimaru K, Utsunomiya A, Ki-Ryang K, Kato T, Itonaga H, Miyazaki Y, Yanagihara K, Oshima K, Arai A, Watanabe T, Yamano Y.
Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia/lymphoma.
Haematologica, 2025 Apr, Epub ahead of print.🆕
doi: 10.3324/haematol.2025.287521.

Araya N, Yamagishi M, Nakashima M, Asahara N, Kiyohara K, Aratani S, Yagishita N, Horibe E, Ishizaki I, Watanabe T, Sato T, Uchimaru K, Yamano Y.
Virus-induced RGMa expression drives neurodegeneration in HTLV-1-associated myelopathy.
JCI insight, 10(11):e184530, 2025 Apr.
doi: 10.1172/jci.insight.184530

Sugata K, Rahman A, Niimura K, Monde K, Ueno T, Rajib SA, Takatori M, Sakhor W, Hossain MB, Sithi SN, Jahan MI, Matsuda K, Ueda M, Yamano Y, Ikeda T, Ueno T, Tsuchiya K, Tanaka Y, Tokunaga M, Maeda K, Utsunomiya A, Okuma K, Ono M, Satou Y.
Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitment.
Nat Microbiol, 10(6):1447-1462, 2025 Apr.
doi: 10.1038/s41564-025-02006-7.

Sato T, Sato M, Nagai K, Fukasawa M, Nagashima Y, Uchida T, Tsutiya A, Omoteyama K, Arito M,
Takakuwa Y, Ooka S, Suematsu N, Kawahata K, Yamano Y, Kato T, Manae SK.
Serum Peptides as Candidate Biomarkers for Relapsing Polychondritis.
J Mass Spectrom Adv Clin Lab, 37:28-38, 2025 Apr.
https://doi.org/10.1016/j.jmsacl.2025.04.001

Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar MZ.
Belatacept Versus Tacrolimus for Kidney Transplant Recipients of Deceased Donors With Acute Kidney Injury: US National Database Study.
Transplantation, 109(4):691-700, 2025 Apr.
DOI: 10.1097/TP.0000000000005196

Fuji S, Tokunaga M, Utsunomiya A, Makiyama J, Suehiro Y, Koh KR, Nakashima M, Yamano Y, Uchimaru K.
Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups.
Ann Hematol, 104:2429-2436, 2025 Mar.
doi: 10.1007/s00277-025-06319-9.

Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar MZ.
Kidney Transplant Outcomes in Amyloidosis: US National Database Study.
Transplantation, 109(3):536-548, 2025 Mar.
DOI: 10.1097/TP.0000000000005191

Sugata K, Takatori M, Reda O, Yang Tan BJ, Tokunaga M, Sato T, Ueda M, Yamano Y, Utsunomiya A, Satou Y.
Effect of Viral Antigen Mismatch on Antiviral T-Cell Response and Immunotherapeutic Efficacy Against Adult T-Cell Leukemia/Lymphoma.
J Infect Dis, 231(3):816-821, 2025 Mar.
https://doi.org/10.1093/infdis/jiae457

Hagiwara Y, Ito H, Fukano T, Shimizu T, Uchida M, Yamano Y.
Utility of carotid ultrasound using microvascular flow imaging for detecting in-stent plaque protrusion after carotid artery stenting.
Clinical Neurology and Neurosurgery, 251:108844, 2025 Mar.
https://doi.org/10.1016/j.clineuro.2025.108844.

Nakashima M, Yamano Y.
Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications.
Clin Exp Neuroimmunol, 16(2): 149–160, 2025 Feb.
https://doi.org/10.1111/cen3.70001

Jimbo K, Nojima M, Toriuchi K, Yamagishi M, Nakashima M, Yamano Y, Uchimaru K & Nannya Y.
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma.
Biomarker Research, 13(1):34, 2025 Feb.
doi: 10.1186/s40364-025-00747-5

Da Silva SJ, Cabral-Castro MJ, Faria LC, Rosadas C, de Araújo MFL, Dutra ACS, Yamano Y, Taylor G, Puccioni-Sohler M.
CXCL-10 in Cerebrospinal Fluid Detects Neuroinflammation in HTLV-1-Associated Myelopathy with High Accuracy.
Viruses, 17(1):89, 2025 Jan.
https://doi.org/10.3390/v17010089

Asigbee TW, Nakamura-Hoshi M, Kuse N,Ishii H, Ishikawa K, Kawana-Tachikawa A, Horibe E, Nakashima M, Yamano Y, Uchimaru K and Matano T.
Virus-host immune interaction 1 in asymptomatic HTLV-1 carriers.
Microbiology Spectrum, 13(3):e0250724, 2025 Jan.
DOI: 10.1128/spectrum.02507-24

大滝 正訓, 廣井 朋子, 立浪 忍, 小林 司, 太田 有紀, 武半 優子, 木田 圭亮, 飯利 太朗, 佐藤 知雄, 松本 直樹.
トリチウム化合物を含む培地中の培養細胞に吸収されるβ線エネルギーの評価について.
日本放射線安全管理学会誌, 24(1):31-37,2025年6月.🆕
https://doi.org/10.11269/jjrsm.24.31

市川 剛大, 清水 高弘, 萩原 悠太, 深野 崇之, 三橋 里美, 宮内 元樹, 斧研 洋幸, 秋山 久尚, 山野 嘉久.
両側椎骨動脈起始部閉塞を伴ったvertebral aetery stump syndromeの1例.
神経超音波医学, 38(1):15-19, 2025年4月.
https://doi.org/10.2301/neurosonology.38.15

赤松 伸太, 水上 平祐, 木村 暁夫, 下畑 享良, 白石 眞, 山野 嘉久*.
繰り返す呼吸不全を認めたIgLON5抗体関連疾患の1例.
臨床神経学, 65:218-223, 2025年3月.
https://doi.org/10.5692/clinicalneurol.cn-002014

正高 佑志、梅村 二葉、三木 直子、秋野 公造、赤星 栄志、三上 礼子、山野 嘉久、太組 一朗.
カンナビノイド製品はどのように使われているのか 国内患者会調査結果の概要.
日本統合医療学会雑誌, 17:1-19, 2025年2月.

八木下 尚子、山野 嘉久.
新規HTLV-1感染カニクイザルモデルを用いたHAMの発症予防法の開発.
オベリスク, 30(1):16-20, 2025年1月.